BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.

Abstract:

:The carboxyl terminus of c-Myb contains a negative regulatory domain that is absent in the v-Myb oncoprotein, but conserved among all the known Myb proteins of animals. This domain inhibits transcriptional activation by c-Myb in animal cells, but not in budding yeast, suggesting that additional protein(s) present in animal cells but not yeast are required for this negative regulatory function. A yeast two-hybrid screen identified BS69, an adenovirus E1A-associated protein, as interacting with the carboxy-terminal region of c-Myb. BS69 contains regions of similarity to the PHD finger, the bromodomain, and the MYND domain, all of which are found in other proteins present in high molecular weight complexes that regulate transcription and/or modify chromatin structure. Further study showed that BS69 inhibited the transcriptional activity of c-Myb, that this inhibition was specific, that it mapped to the carboxyl termini of the two proteins and that it was dose-dependent. A direct interaction between these two proteins was observed in vitro. Furthermore, the 289R E1A protein could inhibit the BS69-mediated decrease in transcriptional activation by c-Myb. By analogy with the inhibition of the Rb/E2F regulatory axis by E1A, we propose that a BS69/Myb regulatory circuit may also be a target of disruption during oncogenesis. Oncogene (2001) 20, 125 - 132.

journal_name

Oncogene

journal_title

Oncogene

authors

Ladendorff NE,Wu S,Lipsick JS

doi

10.1038/sj.onc.1204048

subject

Has Abstract

pub_date

2001-01-04 00:00:00

pages

125-32

issue

1

eissn

0950-9232

issn

1476-5594

pii

1204048

journal_volume

20

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis.

    abstract::Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer among men in the developed world. There is a need, for both clinical and scientific reasons, to find markers to identify patients with aggressive disease as early as possible, and to understand the events leading to malignant transformation ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207345

    authors: Cromer A,Carles A,Millon R,Ganguli G,Chalmel F,Lemaire F,Young J,Dembélé D,Thibault C,Muller D,Poch O,Abecassis J,Wasylyk B

    更新日期:2004-04-01 00:00:00

  • Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells.

    abstract::Dysregulated microRNA (miRNA) mediate malignant phenotypes, including metabolic reprogramming. By performing an integrative analysis of miRNA and metabolome data for the NCI-60 cell line panel, we identified an miRNA cluster strongly associated with both c-Myc expression and global metabolic variation. Within this clu...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.333

    authors: Koufaris C,Valbuena GN,Pomyen Y,Tredwell GD,Nevedomskaya E,Lau CH,Yang T,Benito A,Ellis JK,Keun HC

    更新日期:2016-05-01 00:00:00

  • Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition.

    abstract::Epithelial-mesenchymal transition (EMT) has pivotal roles during embryonic development and carcinoma progression. Members of the Snai1 family of zinc finger transcription factors are central mediators of EMT and induce EMT in part by directly repressing epithelial markers such as E-cadherin, a gatekeeper of the epithe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.234

    authors: Lin T,Ponn A,Hu X,Law BK,Lu J

    更新日期:2010-09-02 00:00:00

  • HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.

    abstract::The dominant paradigm for HPV carcinogenesis includes integration into the host genome followed by expression of E6 and E7 (E6/E7). We explored an alternative carcinogenic pathway characterized by episomal E2, E4, and E5 (E2/E4/E5) expression. Half of HPV positive cervical and pharyngeal cancers comprised a subtype wi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01431-8

    authors: Ren S,Gaykalova DA,Guo T,Favorov AV,Fertig EJ,Tamayo P,Callejas-Valera JL,Allevato M,Gilardi M,Santos J,Fukusumi T,Sakai A,Ando M,Sadat S,Liu C,Xu G,Fisch KM,Wang Z,Molinolo AA,Gutkind JS,Ideker T,Koch WM,Cali

    更新日期:2020-10-01 00:00:00

  • p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.

    abstract::The effect of p53-dependent cell-cycle arrest and senescence on Emu-myc-induced B-cell lymphoma development remains controversial. To address this question, we crossed Emu-myc mice with the p53(515C) mutant mouse, encoding the mutant p53R172P protein that retains the ability to activate the cell-cycle inhibitor and se...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.423

    authors: Post SM,Quintás-Cardama A,Terzian T,Smith C,Eischen CM,Lozano G

    更新日期:2010-03-04 00:00:00

  • Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence.

    abstract::SOX5 is a member of the high-mobility group superfamily of architectural non-histone proteins involved in gene regulation and maintenance of chromatin structure in a wide variety of developmental processes. Sox5 was identified as a brain tumor locus in a retroviral insertional mutagenesis screen of platelet-derived gr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.9

    authors: Tchougounova E,Jiang Y,Bråsäter D,Lindberg N,Kastemar M,Asplund A,Westermark B,Uhrbom L

    更新日期:2009-03-26 00:00:00

  • Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.

    abstract::We have compared the DNase I hypersensitivity of the regulatory region of two estrogen-regulated genes, pS2 and cathepsin D in hormone-dependent and -independent breast carcinoma cell lines. This strategy allowed the identification of two important control regions, one in pS2 and the other in cathepsin D genes. In the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202317

    authors: Giamarchi C,Solanas M,Chailleux C,Augereau P,Vignon F,Rochefort H,Richard-Foy H

    更新日期:1999-01-14 00:00:00

  • Overexpression of estrogen receptor-alpha gene suppresses gap junctional intercellular communication in endometrial carcinoma cells.

    abstract::Stimulation of the endometrium by estrogens without the differentiating effect of progestins is the primary etiological factor associated with the development of endometrial hyperplasia and adenocarcinoma. However, the correlation between sex steroids and gap junctional intercellular communication (GJIC), which is con...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207215

    authors: Saito T,Tanaka R,Wataba K,Kudo R,Yamasaki H

    更新日期:2004-02-05 00:00:00

  • Mouse Neogenin, a DCC-like molecule, has four splice variants and is expressed widely in the adult mouse and during embryogenesis.

    abstract::Neogenin is a member of the N-CAM family of cell adhesion molecules and is closely related to the DCC tumor suppressor gene product. Recently, it has been demonstrated that the DCC/Neogenin subfamily plays a key role in axonal guidance within the embryonic nervous system, however little is known about the function of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201225

    authors: Keeling SL,Gad JM,Cooper HM

    更新日期:1997-08-07 00:00:00

  • Differential modulation of Myb family genes by Ets-2.

    abstract::The myb family of genes encodes highly homologous nuclear transcription factors that play distinct roles in the development of breast, germ cells and hematoid organs. While the mechanisms associated with the regulation of these genes remain unknown, the transactivation of c-Myb was previously shown to be upregulated b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207537

    authors: Kang AD,Park G,Kim YH,Oh IH

    更新日期:2004-05-20 00:00:00

  • Interactions between cancer-associated fibroblasts and tumor cells promote MCL-1 dependency in estrogen receptor-positive breast cancers.

    abstract::Selective inhibition of BCL-2 is expected to enhance therapeutic vulnerability in luminal estrogen receptor-positive breast cancers. We show here that the BCL-2 dependency of luminal tumor cells is nevertheless mitigated by breast cancer-associated fibroblasts (bCAFs) in a manner that defines MCL-1 as another critical...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0635-z

    authors: Louault K,Bonneaud TL,Séveno C,Gomez-Bougie P,Nguyen F,Gautier F,Bourgeois N,Loussouarn D,Kerdraon O,Barillé-Nion S,Jézéquel P,Campone M,Amiot M,Juin PP,Souazé F

    更新日期:2019-04-01 00:00:00

  • DNA damage checkpoint control in cells exposed to ionizing radiation.

    abstract::Damage induced in the DNA after exposure of cells to ionizing radiation activates checkpoint pathways that inhibit progression of cells through the G1 and G2 phases and induce a transient delay in the progression through S phase. Checkpoints together with repair and apoptosis are integrated in a circuitry that determi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206682

    authors: Iliakis G,Wang Y,Guan J,Wang H

    更新日期:2003-09-01 00:00:00

  • Apoptosis-prone phenotype of human colon carcinoma cells with a high level amplification of the c-myc gene.

    abstract::Although apoptosis can be induced by the enforced expression of exogenously introduced c-myc genes, it is not clear whether overexpression resulting from the amplification of the resident c-myc gene in tumor cells is sufficient to induce apoptosis. We have investigated the relationship between c-myc gene amplification...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202309

    authors: Donzelli M,Bernardi R,Negri C,Prosperi E,Padovan L,Lavialle C,Brison O,Scovassi AI

    更新日期:1999-01-14 00:00:00

  • Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.

    abstract::Transforming Growth Factor-beta1 (TGF-beta1) inhibits the proliferation of most cells, but stimulates some mesenchymal cell types, including murine NIH3T3 fibroblasts. We show here that TGF-beta1 growth stimulation of NIH3T3 fibroblasts is reversed when these cells are transformed by SV40 or are transfected with a pla...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202341

    authors: Dkhissi F,Raynal S,Jullien P,Lawrence DA

    更新日期:1999-01-21 00:00:00

  • HPV-16 E7 functions at the G1 to S phase transition in the cell cycle.

    abstract::Previous reports have demonstrated that E7 is the major transforming gene of HPV-16 and that continued expression of the gene is required to maintain the transformed phenotype of primary baby rat kidney cells transformed by HPV-16 E7 and EJ-ras. To investigate the point of action of E7 in the cell cycle we have utilis...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Banks L,Barnett SC,Crook T

    更新日期:1990-06-01 00:00:00

  • Isolation of a new class of 'flat' revertants from ras-transformed NIH3T3 cells using cis-4-hydroxy-L-proline.

    abstract::A new class of nontransformed revertant cells has been isolated from the ras-transformed cell line DT using cis-4-hydroxy-L-proline (CHP) as a selective agent. The new revertants, CHP 9CJ and CHP CB4, each contain two copies of the v-Ki-ras gene, elevated levels of phosphorylated p21ras protein, and rescuable transfor...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Yanagihara K,Ciardiello F,Talbot N,McGeady ML,Cooper H,Benade L,Salomon DS,Bassin RH

    更新日期:1990-08-01 00:00:00

  • MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.

    abstract::Although cell invasion is a necessary early step in cancer metastasis, its regulation is not well understood. We have previously shown, in human prostate cancer, that transforming growth factor beta (TGFbeta)-mediated increases in cell invasion are dependent upon activation of the serine/threonine kinase, p38 MAP kina...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209337

    authors: Xu L,Chen S,Bergan RC

    更新日期:2006-05-18 00:00:00

  • Oncology studies using siRNA libraries: the dawn of RNAi-based genomics.

    abstract::High-throughput, human cell-based applications of RNA-mediated interference (RNAi) have emerged in recent years as perhaps the most powerful of a 'second wave' of functional genomics technologies. The available reagents and methodologies for RNAi screening studies now enable a wide range of different scopes and scales...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208072

    authors: Sachse C,Echeverri CJ

    更新日期:2004-11-01 00:00:00

  • CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.

    abstract::14-3-3sigma proteins regulate numerous cellular processes that are important to cancer development. One of its biological roles involves G2 cell-cycle arrest following DNA damage. It has also been reported that the loss of 14-3-3sigma expression via CpG methylation may contribute to malignant transformation by impairi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209462

    authors: Pulukuri SM,Rao JS

    更新日期:2006-08-03 00:00:00

  • Identification and characterization of a BRAF fusion oncoprotein with retained autoinhibitory domains.

    abstract::Fusion proteins involving the BRAF serine/threonine kinase occur in many cancers. The oncogenic potential of BRAF fusions has been attributed to the loss of critical N-terminal domains that mediate BRAF autoinhibition. We used whole-exome and RNA sequencing in a patient with glioblastoma multiforme to identify a rearr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-1021-1

    authors: Weinberg F,Griffin R,Fröhlich M,Heining C,Braun S,Spohr C,Iconomou M,Hollek V,Röring M,Horak P,Kreutzfeldt S,Warsow G,Hutter B,Uhrig S,Neumann O,Reuss D,Heiland DH,von Kalle C,Weichert W,Stenzinger A,Brors B,Gli

    更新日期:2020-01-01 00:00:00

  • Cell context reveals a dual role for Maf in oncogenesis.

    abstract::Maf b-Zip transcription factors are involved in both terminal differentiation and oncogenesis. To investigate this apparent contradiction, we used two different primary cell types and performed an extensive analysis of transformation parameters induced by Maf proteins. We show that MafA and c-Maf are potent oncogenes ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209171

    authors: Pouponnot C,Sii-Felice K,Hmitou I,Rocques N,Lecoin L,Druillennec S,Felder-Schmittbuhl MP,Eychène A

    更新日期:2006-03-02 00:00:00

  • Growth inhibition of astrocytoma cells by farnesyl transferase inhibitors is mediated by a combination of anti-proliferative, pro-apoptotic and anti-angiogenic effects.

    abstract::While 25% of human cancers harbor oncogenic Ras mutations, such mutations are not found in astrocytomas. We have previously demonstrated that the activation of receptor tyrosine kinases expressed by malignant human astrocytoma cells and specimens results in functional upregulation of the Ras signalling pathway and inc...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203105

    authors: Feldkamp MM,Lau N,Guha A

    更新日期:1999-12-09 00:00:00

  • How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

    abstract::Cancer cells enhance their glycolysis, producing lactate, even in the presence of oxygen. Glycolysis is a series of ten metabolic reactions catalysed by enzymes whose expression is most often increased in tumour cells. HKII and phosphoglucose isomerase (PGI) have mainly an antiapoptotic effect; PGI and glyceraldehyde-...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2014.320

    authors: Lincet H,Icard P

    更新日期:2015-07-01 00:00:00

  • Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells.

    abstract::There have been few studies on the specific signaling pathways involved in the transformation of epithelial cells by oncogenic protein tyrosine kinases. Here we investigate the requirement of MAP (MAPK) and phosphatidylinositol 3- (PI3K) kinases in the transformation of rat intestinal epithelial (RIE) cells by oncogen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203911

    authors: Nguyen KT,Wang WJ,Chan JL,Wang LH

    更新日期:2000-11-09 00:00:00

  • Mimicking the BH3 domain to kill cancer cells.

    abstract::Cancer cells show deviant behavior that induces apoptotic signaling. To survive, cancer cells typically acquire changes enabling evasion of death signals. One way they do this is by increasing the expression of anti-apoptotic BCL-2 proteins. Anti-apoptotic BCL-2 family proteins antagonize death signaling by forming he...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2009.52

    authors: Ni Chonghaile T,Letai A

    更新日期:2008-12-01 00:00:00

  • Inactivation of hTERT transcription by Tax.

    abstract::Telomerase expression is the hallmark of tumor cells in which this ribonucleoprotein complex preserves chromosome integrity by maintaining telomere length and thereby prevents cell death. However, recent data support a role of the combination of p53 and telomerase inactivation in initiating genetic instability that pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206468

    authors: Gabet AS,Mortreux F,Charneau P,Riou P,Duc-Dodon M,Wu Y,Jeang KT,Wattel E

    更新日期:2003-06-12 00:00:00

  • Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor.

    abstract::The mouse mammary epithelial cell hierarchy contains both multipotent stem cell as well as lineage-limited duct and lobular progenitor cell functions. The latter-also termed parity-identified mammary epithelial cells (PI-MECs)-are marked by beta-galactosidase (β Gal) expression following pregnancy and involution in wh...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.215

    authors: Bruno RD,Boulanger CA,Smith GH

    更新日期:2012-01-05 00:00:00

  • Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.

    abstract::The proto-oncogene BMI1 and its product, Bmi1, is overexpressed in various types of tumors, particularly in aggressive tumors and tumors resistant to conventional chemotherapy. BMI1/Bmi1 is also crucially involved in cancer-initiating cell maintenance, and is recurrently upregulated in mantle cell lymphoma (MCL), espe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.177

    authors: Teshima K,Nara M,Watanabe A,Ito M,Ikeda S,Hatano Y,Oshima K,Seto M,Sawada K,Tagawa H

    更新日期:2014-04-24 00:00:00

  • Site-specific DNA methylation by a complex of PU.1 and Dnmt3a/b.

    abstract::The Ets transcription factor PU.1 is a hematopoietic master regulator essential for the development of myeloid and B-cell lineages. As we previously reported, PU.1 sometimes represses transcription on forming a complex with mSin3A-histone deacetyl transferase-MeCP2. Here, we show an interaction between PU.1 and DNA me...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209272

    authors: Suzuki M,Yamada T,Kihara-Negishi F,Sakurai T,Hara E,Tenen DG,Hozumi N,Oikawa T

    更新日期:2006-04-20 00:00:00

  • FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5/NOTCH2 signaling node.

    abstract::Basal type breast cancer is the most aggressive and has mesenchymal features with a high metastatic ability. However, the signaling node that determines the basal type features in breast cancer remains obscure. Here, we report that FYN among SRC family kinases is required for the maintenance of basal type breast cance...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-017-0114-y

    authors: Lee GH,Yoo KC,An Y,Lee HJ,Lee M,Uddin N,Kim MJ,Kim IG,Suh Y,Lee SJ

    更新日期:2018-04-01 00:00:00